Expert discusses limitations of the vitamin D blood test


“The idea of generally screening everyone right now is not only costly, but it's not recognizing the fact that this comes with a lot of limitations,” says Mark A. Moyad, MD, MPH.

In this video, Mark A. Moyad, MD, MPH, discusses the limitations of vitamin D blood tests, focusing on the possibility for low or high levels of vitamin D to be misinterpreted. Moyad is the Jenkins/Pomkempner Director of Complementary Alternative Medicine in the Department of Urology at the University of Michigan Medical Center in Ann Arbor, Michigan.

Recent Videos
Video 2 - "Exploring Treatments for BCG-Unresponsive Intermediate-High Risk NMIBC"
Video 1 "Unmet Needs & Standard of Care for Intermediate-High Risk NMIBC"
Video 4 - "The Role of a Multidisciplinary Team in Managing Kidney Cancer"
Video 2 - "Diagnostic Tests for Kidney Cancer"
Video 1 - "A Growing Incidence of Renal Masses"
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
© 2024 MJH Life Sciences

All rights reserved.